Relieve Therapeutics is a clinical stage biopharma company founded to be a game changer in pain management through developing effective, non-invasive, portable alternatives to oral analgesics.
Our proprietary HYAZIN™ platform enhances skin penetration and supports the delivery of therapeutics, including hydrophilic, high molecular weight compounds, into deep dermal tissues. This breakthrough enables precise drug delivery through an innovative dry powder spray format.
One Platform, Endless Possibilities
Our proprietary HYAZIN™ platform transforms analgesics into targeted topical therapy, which enables a robust pipeline of breakthrough treatments across multiple pain conditions.
1st Indication: Painful Diabetic Peripheral Neuropathy
A life-crippling disease for millions currently lacking safe and effective treatment.
Our completed Phase 2a clinical trial with lead asset ZRP-001 demonstrated significant pain relief (4.8 point reduction on NPRS and 77% of subjects achieving ≧50% pain reduction). There were no reported adverse events or skin reactions.
.png)
19+ years of investment and business development experience across healthcare and other sectors
.png)
23+ years of R&D experience with strong focus on pharmaceuticals, nutraceuticals and medical devices
24+ years of experience in topical product development, clinical development and regulatory affairs